Abbott to Separate into Two Leading Companies in Diversified Medical Products and Research-Based Pharmaceuticals
Two publicly traded companies will offer shareholders distinct opportunities given unique investment identities, business profiles and attributes Builds on a decade of strategic and operational advancements ABBOTT PARK, Ill., Oct. 19, 2011 – Today Abbott announced that it plans to separate into two publicly traded companies, one in diversified medical products and the other in research-based pharmaceuticals. The diversified medical products company will consist of Abbott's existing diversified medical products portfolio, including its branded generic pharmaceutical, devices,